Tango Therapeutics, Inc. · NASDAQ:TNGX
Azelby Robert received 5,740 Tango Therapeutics, Inc. shares as an award (Form 4)
Traded Jun 19, 2026 · Filed Jun 23, 2026
On Jun 19, 2026, Azelby Robert (Director) received 5,740 Tango Therapeutics, Inc. shares as an award, leaving 5,740 shares. Filed Jun 23, 2026 (Form 4).
- Awarded
- 5,740 shares
- Holding after
- 5,740 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 19, 2026 | Common Stock | Award | 5,740 | 5,740 | Direct |